Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis

MLA

Stefano Di Donato, et al. “Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis.” Current Drug Metabolism, vol. 21, no. 11, May 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5b46c3c787b56764711db9da7ddefc39&authtype=sso&custid=ns315887.

APA

Stefano Di Donato, Antonio Picardi, Paolo Gallo, Giovanni Galati, Antonio Fabio Massimo Vainieri, Marianna Silletta, Claudia Angela Maria Fulgenzi, Umberto Vespasiani-Gentilucci, & Angelo Onorato. (2020). Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis. Current Drug Metabolism, 21(11).

Chicago

Stefano Di Donato, Antonio Picardi, Paolo Gallo, Giovanni Galati, Antonio Fabio Massimo Vainieri, Marianna Silletta, Claudia Angela Maria Fulgenzi, Umberto Vespasiani-Gentilucci, and Angelo Onorato. 2020. “Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis.” Current Drug Metabolism 21 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5b46c3c787b56764711db9da7ddefc39&authtype=sso&custid=ns315887.